Article    Table of Contents                    Full Text of this article    PDF of this article (PDFs free after 6 months)    Summary for Patients    Figures/Tables List    Related articles in Annals  Services    Send comment/rapid response letter    Notify a friend about this article    Alert me when this article is cited    Add to Personal Archive    Download to Citation Manager    ACP Search                            Get Permissions  Google Scholar    Search for Related Content  PubMed Articles in PubMed by Author:    Baumgartner, I.    Isner, J. M.    Related Articles in PubMed    PubMed Citation    PubMed

BRIEF COMMUNICATION

Lower-Extremity Edema Associated with Gene Transfer of Naked DNA Encoding Vascular Endothelial Growth Factor

Iris Baumgartner, MD; Guenter Rauh, MD; Ann Pieczek, RN; Debra Wuensch, RN; Meredith Magner, BA; Marianne Kearney, BS; Robert Schainfeld, DO; and Jeffrey M. Isner, MD

6 June 2000 | Volume 132 Issue 11 | Pages 880-884

Background: Vascular endothelial growth factor (VEGF) promotes angiogenesis and vascular permeability. The extent to which VEGF may cause tissue edema in humans has not been established.

Objective: To evaluate patients undergoing VEGF gene transfer for evidence of lower-extremity edema.

Design: Prospective consecutive case series.

Setting: Hospital outpatient clinic.

Patients: 62 patients with critical limb ischemia and 28 patients with claudication.

Intervention: Gene transfer of VEGF DNA.

Measurements: Semiquantitative analysis of lower-extremity edema.

Results: Lower-extremity edema was observed in 31 of 90 (34%) patients. Edema was less common in patients with claudication than in those with pain at rest (P = 0.016) or ischemic ulcers (P < 0.001), and it was less common in patients with pain at rest than in those with ischemic ulcers (P = 0.017). Treatment was typically limited to a brief course of oral diuretics.

Conclusions: Vascular endothelial growth factor may enhance vascular permeability in humans. At the doses of plasmid DNA used in this study, lower-extremity edema responded to oral diuretic therapy and did not seem to be associated with serious sequelae.

Author and Article Information

From St. Elizabeth's Medical Center, Tufts University School of Medicine, Boston, Massachusetts.

Grant Support: In part by an Academic Award in Vascular Medicine (HL 02824) and grants HL53354 and HL57516 from the National Institutes of Health, Bethesda, Maryland, and by the E.L. Weigand Foundation, Reno, Nevada. Dr. Baumgartner is the recipient of a Swiss National Science Foundation grant. Dr. Rauh is the recipient of a German Humboldt Foundation grant.

Requests for Single Reprints: Jeffrey M. Isner, MD, St. Elizabeth's Medical Center of Boston, 736 Cambridge Street, Boston, MA 02135; e-mail, jisner{at}opal.tufts.edu.

Requests To Purchase Bulk Reprints (minimum, 100 copies): the Reprints Coordinator; phone, 215-351-2657; e-mail, reprints{at}mail.acponline.org.

Current Author Addresses: Dr. Baumgartner: University Freiburgstrasse, 3010 Berne, Switzerland.

Dr. Rauh, Ms. Pieczek, Ms. Wuensch, Ms. Magner, Ms. Kearney, Dr. Schainfeld, and Dr. Isner: St. Elizabeth's Medical Center of Boston, 736 Cambridge Street, Boston, MA 02135.

Author Contributions: Conception and design: J.M. Isner.

Analysis and interpretation of the data: I. Baumgartner, G. Rauh, R. Schainfeld, J.M. Isner.

Drafting of the article: I. Baumgartner, G. Rauh.

Critical revision of the article for important intellectual content: A. Pieczek, D. Wuensch, M. Magner, M. Kearney, R. Schainfeld, J.M. Isner.

Final approval of the article: A. Pieczek, D. Wuensch, M. Magner, M. Kearney, R. Schainfeld, J.M. Isner.

Administrative, technical, or logistic support: A. Pieczek, D. Wuensch, M. Magner, M. Kearney, J.M. Isner.

Collection and assembly of data: A. Pieczek, D. Wuensch, M. Magner, M. Kearney.

Related articles in Annals:

Summaries for Patients
Leg Swelling after Gene Therapy for Peripheral Vascular Disease

Annals 2000 132: 880. [Full Text]  

This article has been cited by other articles:

				J. E. Sears, G. Hoppe, Q. Ebrahem, and B. Anand-Apte Prolyl hydroxylase inhibition during hyperoxia prevents oxygen-induced retinopathy PNAS, December 16, 2008; 105(50): 19898 - 19903. [Abstract] [Full Text] [PDF]

				E. Shi, X. Jiang, T. Kazui, N. Washiyama, K. Yamashita, H. Terada, and A. H. M. Bashar Nonviral gene transfer of hepatocyte growth factor attenuates neurologic injury after spinal cord ischemia in rabbits J. Thorac. Cardiovasc. Surg., October 1, 2006; 132(4): 941 - 947. [Abstract] [Full Text] [PDF]

				M. E. Gerritsen HGF and VEGF: A Dynamic Duo Circ. Res., February 18, 2005; 96(3): 272 - 273. [Full Text] [PDF]

				Q. Dai, J. Huang, B. Klitzman, C. Dong, P. J. Goldschmidt-Clermont, K. L. March, J. Rokovich, B. Johnstone, E. J. Rebar, S. K. Spratt, et al. Engineered Zinc Finger-Activating Vascular Endothelial Growth Factor Transcription Factor Plasmid DNA Induces Therapeutic Angiogenesis in Rabbits With Hindlimb Ischemia Circulation, October 19, 2004; 110(16): 2467 - 2475. [Abstract] [Full Text] [PDF]

				M. Shimamura, N. Sato, K. Oshima, M. Aoki, H. Kurinami, S. Waguri, Y. Uchiyama, T. Ogihara, Y. Kaneda, and R. Morishita Novel Therapeutic Strategy to Treat Brain Ischemia: Overexpression of Hepatocyte Growth Factor Gene Reduced Ischemic Injury Without Cerebral Edema in Rat Model Circulation, January 27, 2004; 109(3): 424 - 431. [Abstract] [Full Text] [PDF]

				K. Hiraoka, H. Koike, S. Yamamoto, N. Tomita, C. Yokoyama, T. Tanabe, T. Aikou, T. Ogihara, Y. Kaneda, and R. Morishita Enhanced Therapeutic Angiogenesis by Cotransfection of Prostacyclin Synthase Gene or Optimization of Intramuscular Injection of Naked Plasmid DNA Circulation, November 25, 2003; 108(21): 2689 - 2696. [Abstract] [Full Text] [PDF]

				T. Li, K. Tachibana, M. Kuroki, and M. Kuroki Gene Transfer with Echo-enhanced Contrast Agents: Comparison between Albunex, Optison, and Levovist in Mice--Initial Results Radiology, November 1, 2003; 229(2): 423 - 428. [Abstract] [Full Text] [PDF]

				J.-S. Silvestre, N. Kamsu-Kom, M. Clergue, M. Duriez, and B. I. Levy Very-Low-Dose Combination of the Angiotensin-Converting Enzyme Inhibitor Perindopril and the Diuretic Indapamide Induces an Early and Sustained Increase in Neovascularization in Rat Ischemic Legs J. Pharmacol. Exp. Ther., December 1, 2002; 303(3): 1038 - 1043. [Abstract] [Full Text] [PDF]

				S. Pislaru, S. P. Janssens, B. J. Gersh, and R. D. Simari Defining Gene Transfer Before Expecting Gene Therapy: Putting the Horse Before the Cart Circulation, July 30, 2002; 106(5): 631 - 636. [Full Text] [PDF]

				J. M. Isner, P. R. Vale, J. F. Symes, and D. W. Losordo Assessment of Risks Associated With Cardiovascular Gene Therapy in Human Subjects Circ. Res., August 31, 2001; 89(5): 389 - 400. [Abstract] [Full Text] [PDF]

				S. E. Epstein, R. Kornowski, S. Fuchs, and H. F. Dvorak Angiogenesis Therapy : Amidst the Hype, the Neglected Potential for Serious Side Effects Circulation, July 3, 2001; 104(1): 115 - 119. [Full Text] [PDF]

				S. C. FRANCIS, M. K. RAIZADA, A. A. MANGI, L. G. MELO, V. J. DZAU, P. R. VALE, J. M. ISNER, D. W. LOSORDO, J. CHAO, M. J. KATOVICH, et al. Genetic targeting for cardiovascular therapeutics: are we near the summit or just beginning the climb? Physiol Genomics, December 21, 2001; 7(2): 79 - 94. [Abstract] [Full Text] [PDF]